Keywords: Patent settlement, Imax Labs, Genzyme, Sanofi, Renvela, Renagel

Impax Labs settles with Genzyme over Renvela and Renagel generics

Article | 05 September 2012

Print This

USA-based Impax Laboratories (Nasdaq: IPXL) says it has reached agreement with French drug major Sanofi’s (Euronext: SAN) biotech ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in